Moxifloxacin Monotherapy Is Effective in Hospitalized Patients with Community‐Acquired Pneumonia: The MOTIV Study—A Randomized Clinical Trial

200879 citationsJournal Article

Authors

Antoni Torres · Universitat de Barcelona

Javier Garau · Universitat de Barcelona

Pierre Arvis · Hôpital Saint Joseph

Jean Carlet · Hôpital Saint Joseph

Shurjeel Choudhri · Bayer (Canada)

A Kureishi · Charité - Universitätsmedizin Berlin

Marie‐Aude Le Berre ·

Abstract

Monotherapy with sequential intravenous/oral moxifloxacin was noninferior to treatment with ceftriaxone plus levofloxacin combination therapy in patients with community-acquired pneumonia who required hospitalization.

Topics & Keywords

Pneumonia and Respiratory Infections Antibiotics Pharmacokinetics and Efficacy Antibiotic Resistance in Bacteria

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Infectious Diseases

Volume 46, Issue 10, pp. 1499-1509

DOI: 10.1086/587519

Field-Weighted Citation Impact: 7.25